JNJ

226.17

-0.57%↓

UNH

367.12

-0.51%↓

TMO

467.38

-0.4%↓

ISRG

455.94

-0.36%↓

ABT

89.02

-0.55%↓

JNJ

226.17

-0.57%↓

UNH

367.12

-0.51%↓

TMO

467.38

-0.4%↓

ISRG

455.94

-0.36%↓

ABT

89.02

-0.55%↓

JNJ

226.17

-0.57%↓

UNH

367.12

-0.51%↓

TMO

467.38

-0.4%↓

ISRG

455.94

-0.36%↓

ABT

89.02

-0.55%↓

JNJ

226.17

-0.57%↓

UNH

367.12

-0.51%↓

TMO

467.38

-0.4%↓

ISRG

455.94

-0.36%↓

ABT

89.02

-0.55%↓

JNJ

226.17

-0.57%↓

UNH

367.12

-0.51%↓

TMO

467.38

-0.4%↓

ISRG

455.94

-0.36%↓

ABT

89.02

-0.55%↓

Kodu・Aktsiate loetelu・Nektar Therapeutics

Search

Nektar Therapeutics

Avatud

87.37 1.02

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

85.51

Max

88.08

Põhinäitajad
By Trading Economics
Sissetulek	-557K -36M
Müük	10M 22M
Aktsiakasum	-1.29
Kasumimarginaal	-165.447
Töötajad	63
EBITDA	10M -19M

Soovitused
By TipRanks
Soovitused	Tugev "osta" hinnang
12 kuu keskmine prognoos	+60.05% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	7. mai 2026

Turustatistika
By TradingEconomics
Turukapital	946M 2.9B
Eelmine avamishind	86.35
Eelmine sulgemishind	87.37

Tehniline skoor

By Trading Central

Kindlus

Strong Bearish Evidence

0.5949 / 0.7406 Toetus ja vastupanu

Nektar Therapeutics Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

3. mai 2026, 23:47 UTC

Tulu

National Australia Bank Warns of Economic Shock as 1st Half Profit Falls -- Update

3. mai 2026, 22:35 UTC

Tulu

National Australia Bank Holds Dividend Despite 19% 1st Half Profit Drop

3. mai 2026, 23:39 UTC

Market Talk

Gold Edge Higher Amid Signs of Resilience -- Market Talk

3. mai 2026, 23:34 UTC

Market Talk

Oil Declines Amid Mild Risk-on Sentiment -- Market Talk

3. mai 2026, 23:32 UTC

Tulu

National Australia Bank Warns of Economic Shock as 1H Profit Falls -- Update

3. mai 2026, 23:30 UTC

Market Talk

Nickel Industries Result Shows Power of Higher Prices -- Market Talk

3. mai 2026, 23:20 UTC

Market Talk

RBA Likely to Hike Rates; Guidance and Board Split Key -- Market Talk

3. mai 2026, 23:16 UTC

Omandamised, ülevõtmised, äriostud

GameStop Is Offering to Buy eBay for $56 Billion, CEO Ryan Cohen Says -- WSJ

3. mai 2026, 22:57 UTC

Omandamised, ülevõtmised, äriostud

GameStop Is Offering to Buy eBay For $56 Billion, CEO Ryan Cohen Says -- WSJ

3. mai 2026, 22:57 UTC

Omandamised, ülevõtmised, äriostud

GameStop Has Roughly 5% Stake in eBay, Cohen Says -- WSJ

3. mai 2026, 22:57 UTC

Omandamised, ülevõtmised, äriostud

GameStop Offering to Buy eBay for $125 a Share, or About $56 Billion, CEO Ryan Cohen Says -- WSJ

3. mai 2026, 22:57 UTC

Omandamised, ülevõtmised, äriostud

GameStop Is Prepared to Run Proxy Fight If eBay Isn't Receptive to a Deal, Cohen Says -- WSJ

3. mai 2026, 22:57 UTC

Omandamised, ülevõtmised, äriostud

GameStop Has Around $20 Billion in Debt Financing Committed From TD Bank, Cohen Says -- WSJ

3. mai 2026, 22:45 UTC

Market Talk

Global Equities Roundup: Market Talk

3. mai 2026, 22:45 UTC

Market Talk

Low-Cost Miners in Spotlight Amid High Energy Prices -- Market Talk

3. mai 2026, 22:20 UTC

Tulu

National Australia Bank Holds Dividend Despite 19% 1H Profit Drop

3. mai 2026, 22:08 UTC

Tulu

NAB's 1H Included Previously Announced A$1.35B Software Amortization Charge>NAB.AU

3. mai 2026, 22:05 UTC

Tulu

NAB 1H Net Interest Income A$9.16B Vs. A$8.445B>NAB.AU

3. mai 2026, 22:05 UTC

Tulu

NAB 1H Credit Impairment Charge A$706M Vs. A$348M>NAB.AU

3. mai 2026, 22:05 UTC

Tulu

NAB 1H Operating Expenses A$5.02B Vs. A$4.81B>NAB.AU

3. mai 2026, 22:04 UTC

Tulu

NAB 1H Net Interest Margin 1.81%>NAB.AU>NAB.AU

3. mai 2026, 22:03 UTC

Tulu

NAB 1H Cash Return on Equity Ex-Large Notable Items 11.6%>NAB.AU

3. mai 2026, 22:03 UTC

Tulu

NAB 1H Cash Return on Equity 8.5%>NAB.AU

3. mai 2026, 22:02 UTC

Tulu

NAB 1H CET1 Capital Ratio 11.65% Vs. 12.01%>NAB.AU

3. mai 2026, 22:02 UTC

Tulu

NAB 1H Cash Earnings A$2.64B>NAB.AU

3. mai 2026, 22:02 UTC

Tulu

NAB 1H Cash Earnings Ex-Notable Items A$3.59B Vs. A$3.58B>NAB.AU

3. mai 2026, 22:01 UTC

Tulu

National Australia Bank Keeps Dividend at A$0.85 >NAB.AU

3. mai 2026, 22:01 UTC

Tulu

National Australia Bank 1H Rev A$11.16B Vs. A$10.28B >NAB.AU

3. mai 2026, 22:01 UTC

Tulu

National Australia Bank 1H Net A$2.75B Vs. Net A$3.41B >NAB.AU

3. mai 2026, 15:06 UTC

Tulu

Berkshire's Greg Abel Marks His First Annual Meeting as CEO. We'd Give Him a B-Plus. -- Barrons.com

Võrdlus sarnastega

Hinnamuutus

Nektar Therapeutics Prognoos

Hinnasiht

By TipRanks

60.05% tõus

12 kuu keskmine prognoos

Keskmine 138.38 USD 60.05%

Kõrge 185 USD

Madal 95 USD

Põhineb 8 Wall Streeti analüütiku instrumendi Nektar Therapeutics 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

8 ratings

7

Osta

1

Hoia

0

Müü

Põhineb 8 analüütiku instrumendi Nektar Therapeutics aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

0.5949 / 0.7406Toetus ja vastupanu

Recent bearish events outweigh bullish events.

All events are bearish.

All events are bearish.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Muud aktsiad sektorist

JNJ

Johnson and Johnson

226.17

UNH

UnitedHealth Group Inc

367.12

TMO

Thermo Fisher Scientific Inc

467.38

ISRG

Intuitive Surgical Inc

455.94

ABT

Abbott Laboratories

89.02

Live chat